This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (54)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

R. W. Fincham, MD; D. D. Schottelius, PhD; A. L. Sahs, MD

Arch Neurol. 1974;30(3):259-262.

Abstract
The interaction of primidone with its metabolites and other antiepileptic drugs is a complex, pertinent, and little investigated subject. Phenobarbital, one of the major metabolites of primidone, usually appears in the serum of patients 24 to 96 hours after initiation of therapy. The conversion of primidone to phenobarbital and the factors that may influence this ratio is an important consideration in patient care. The influence of diphenylhydantoin on the phenobarbital:primidone ratio has been investigated in patients examined in our clinic. Fifteen patients taking only primidone have a low ratio (1.05 ± 0.20); two of these had been taking primidone for several years and have no detectable amounts of phenobarbital. The conversion ratio of 44 patients taking primidone and diphenylhydantoin is significantly higher (4.35 ± 0.50). Apparently diphenylhydantoin promotes the induction of an enzyme system responsible for the oxidation of primidone.

Author Affiliations
Iowa City

From the Department of Neurology, University of Iowa, Iowa City.

Footnotes
Accepted for publication Oct 9, 1973.

Read in part before the joint annual meeting of the American Neurological Association and the Canadian Congress of Neurological Sciences, Montreal, June 12, 1973.

Reprint requests to Department of Neurology, University Hospital, Iowa City 52242 (Dr. Fincham).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Drug Spotlight Program: The Use of Antiepileptic Drugs
PENRY and NEWMARK
ANN INTERN MED 1979;90:207-218.
ABSTRACT  

Rickets in Children Receiving Anticonvulsant Drugs: Biochemical and Hormonal Markers
Winnacker et al.
Arch Pediatr Adolesc Med 1977;131:286-290.
ABSTRACT  

Acetazolamide-Induced Interference With Primidone Absorption: Case Reports and Metabolic Studies
Syversen et al.
Arch Neurol 1977;34:80-84.
ABSTRACT  

Usefulness of Blood Levels of Antiepileptic Drugs
Kutt and Penry
Arch Neurol 1974;31:283-288.
ABSTRACT